Основная статистика
| LEI | HDBLS2Q6GV1LSKQPBS54 |
| CIK | 915913 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Albemarle Corporation
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2025 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2025 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| July 30, 2025 |
Exhibit 99.1 Contact: [email protected] 1.980.299.5700 Albemarle Reports Second Quarter 2025 Results CHARLOTTE, N.C. – July 30, 2025 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2025. Second-Quarter 2025 and Recent Highlights (Unless otherwise |
|
| July 30, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 30, 2025 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file num |
|
| June 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-12658 A. Full title of the plan and the ad |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALBEMARLE CORPORATION (Exact name of registrant as specified in its charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 4250 Congress Street, Suite 900, Charlotte, North Carolina 28 |
|
| May 9, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 30, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 30, 2025 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file nu |
|
| April 30, 2025 |
Form of Stock Option Award Agreement under the Albemarle Corporation 2017 Incentive Plan Exhibit 10.1 STOCK OPTION AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of /$GrantDate$/, Albemarle Corporation, a Virginia corporation (the “Company”), and /$ParticipantName$/ (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as defined below) made pursuant to the Company’s 2017 Inc |
|
| April 30, 2025 |
Exhibit 10.3 RESTRICTED STOCK UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of /$GrantDate$/, Albemarle Corporation, a Virginia corporation (the “Company”), and /$ParticipantName$/ (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as defined below) made pursuant to the Company’s |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| April 30, 2025 |
Exhibit 99.1 Contact: [email protected] 1.980.299.5700 Albemarle Reports First Quarter 2025 Results CHARLOTTE, N.C. – Apr. 30, 2025 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights (Unless otherwise st |
|
| April 30, 2025 |
Exhibit 10.4 RESTRICTED STOCK UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of /$GrantDate$/, Albemarle Corporation, a Virginia corporation (the “Company”), and /$ParticipantName$/ (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as defined below) made pursuant to the Company’s |
|
| April 30, 2025 |
Form of Performance Unit Award Agreement under the Albemarle Corporation 2017 Incentive Plan Exhibit 10.2 PERFORMANCE UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of /$GrantDate$/, Albemarle Corporation, a Virginia corporation (the “Company”), and /$ParticipantName$/ (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as defined below) made pursuant to the Company’s 2017 |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMA |
|
| March 31, 2025 |
Exhibit 23.7 Consent of Independent Auditors We consent to the incorporation by reference in the registration statement (No. 333-269815) on Form S-3 and registration statements (No. 333-150694, 333-166828, 333-188599, 333-223167 and 333-271578) on Form S-8 of Albemarle Corporation of our report dated March 26, 2024, with respect to the consolidated financial statements of Windfield Holdings Pty Lt |
|
| March 31, 2025 |
Financial Statements of Windfield Holdings Pty Ltd for the year ended December 31, 2024. Exhibit 99.1 WINDFIELD HOLDINGS PTY LTD ABN: 60 160 456 164 Annual Report 31 December 2024 Expressed in thousands of Australian dollars (A$000) unless otherwise stated Consolidated statement of profit or loss and other comprehensive income For the year ended 31 December 2024 2023 2022 (Unaudited) Note A$'000 A$'000 A$'000 Sales revenue 1,970,629 9,868,260 5,574,748 Cost of sales 4(a) (743,076) (93 |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) X Definitive Proxy |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy S |
|
| February 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 12, 2025 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| February 12, 2025 |
Exhibit 99.1 Contact: [email protected] 1.980.299.5700 Albemarle Reports Fourth Quarter and Full Year 2024 Results CHARLOTTE, N.C. – Feb. 12, 2025 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year |
|
| February 12, 2025 |
exhibit965jbc2024trs respec.com JORDAN BROMINE OPERATION Technical Report Summary as of December 31, 2024 716-RPS223461 Final 12 February 2025 Exhibit 96.5 TECHNICAL REPORT SUMMARY 716-RPS223461 | Jordan Bromine Operation | Final | 12 February 2025 rpsgroup.com Page ii JORDAN BROMINE OPERATION Technical Report Summary Peer Review Michael Gallup, P. Eng. [email]: [email protected] 24 Janu |
|
| February 12, 2025 |
exhibit966magnolia2024tr rpsgroup.com MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2024 Magnolia, Arkansas, USA, property of Albemarle Corporation 716-RPS223461 Final 12 February 2025 Exhibit 96.6 RESERVE EVALUATION 716-RPS223461 | MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2024 | Final | 12 February 2025 rpsgroup.com Page ii MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2024 Ma |
|
| February 12, 2025 |
Exhibit 4.13 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED As of December 31, 2024, Albemarle Corporation, a Virginia corporation (“Albemarle” or the “Company”), had two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: (i) common stock and (ii) depositary shares (the “Depositary |
|
| February 12, 2025 |
exhibit962wodgina2024trs Technical Report Summary, Wodgina Operation, Western Australia Albemarle Corporation Date: 10 February 2025 Exhibit 96. |
|
| February 12, 2025 |
Albemarle Corporation Insider Trading Policy, effective as of October 4, 2024 Exhibit 19 Insider Trading Policy 1.PURPOSE AND SCOPE This Insider Trading Policy (this “Policy”) provides guidelines regarding transactions in the securities of Albemarle Corporation (“Albemarle” or the “Company”) and the handling of material non-public information about the Company and the companies with which Albemarle does business. Albemarle has adopted this Policy, effective October 4, 2024, |
|
| February 12, 2025 |
Technical Report Summary, Greenbushes Mine, Western Australia Albemarle Corporation Date: 10 February 2025 Exhibit 96. |
|
| February 12, 2025 |
exhibit964silverpeak2024 SEC Technical Report Summary Prefeasibility Study Silver Peak Lithium Operation Nevada, USA Effective Date: June 30, 2024 Report Date: February 8, 2025 Report Prepared for Albemarle Corporation 4250 Congress Street Suite 900 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U. |
|
| February 12, 2025 |
Amended and Restated Articles of Incorporation of Albemarle Corporation Exhibit 3.1 [Restated electronically for SEC filing purposes only] AMENDED AND RESTATED ARTICLES OF INCORPORATION OF ALBEMARLE CORPORATION I. The name of the Corporation is Albemarle Corporation. II. The purpose for which the Corporation is formed is to transact any or all lawful business, not required to be specifically stated in these Articles, for which corporations may be incorporated under th |
|
| February 12, 2025 |
SEC Technical Report Summary Prefeasibility Study Salar de Atacama Región II, Chile Effective Date: June 30, 2024 Report Date: February 8, 2025 Report Prepared for Albemarle Corporation 4250 Congress Street Suite 900 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U. |
|
| February 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 12, 2025 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| February 12, 2025 |
Exhibit 21.1 SUBSIDIARIES OF ALBEMARLE CORPORATION NAME PLACE OF FORMATION ACI Cyprus, L.L.C. Delaware Albemarle Amendments, LLC Delaware Albemarle Argentina S.R.L. Argentina Albemarle Chemical Canada Ltd. Canada Albemarle Chemicals (Shanghai) Co., Ltd. China Albemarle Chemicals Ltd Cyprus Albemarle Chemicals SAS France Albemarle Chemicals South Africa (Proprietary) Limited South Africa Albemarle |
|
| February 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMARLE CORPORATION (Exa |
|
| February 12, 2025 |
Form of Executive Change in Control Agreement. Exhibit 10.30 Albemarle Corporation 4250 Congress Street, Suite 900 Charlotte, NC 28209 , 20 Dear : The Board of Directors (the “Board”) of Albemarle Corporation (the “Corporation”) recognizes that the possibility of a Change in Control of the Corporation exists, and the uncertainty and questions which it may raise among management may result in the departure or distraction of management personnel |
|
| December 5, 2024 |
ALB / Albemarle Corporation / Capital World Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Albemarle Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 012653101 (CUSIP Number) November 29, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des |
|
| November 13, 2024 |
ALB / Albemarle Corporation / Capital World Investors - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Albemarle Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 012653101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| November 13, 2024 |
ALB / Albemarle Corporation / Capital International Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Albemarle Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 012653101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| November 12, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Albemarle Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 012653101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEM |
|
| November 6, 2024 |
Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT, dated as of October 31, 2024 (this “Amendment”), is entered into among ALBEMARLE CORPORATION, a Virginia corporation (the “Company”), ALBEMARLE EUROPE SRL, a société à responsabilité limitée organized under the laws of Belgium (“Belgian Borrower” and, together with the Company and any other Subsidiary of t |
|
| November 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 6, 2024 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| November 6, 2024 |
Exhibit 99.1 Contact: [email protected] 1.980.299.5700 Albemarle Reports Third Quarter 2024 Results CHARLOTTE, N.C. – November 6, 2024 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2024. Third-Quarter 2024 and Recent Highlights (Unless other |
|
| October 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2024 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File |
|
| October 16, 2024 |
ALB / Albemarle Corporation / STATE STREET CORP Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ALBEMARLE CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 012653101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ý R |
|
| October 7, 2024 |
Exhibit 99.1 Albemarle Announces New Operating Structure to Increase Agility, Drive Cost Efficiencies and Maintain Long-Term Competitiveness Decision marks next step in comprehensive review of cost and operating structure CHARLOTTE, N.C., Oct. 7, 2024 – Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced |
|
| October 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2024 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File |
|
| September 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALBEMARLE CORPORATION (Exact name of registrant as specified in its charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 4250 Congress Street, Suite 900, Charlotte, North Carolina 28 |
|
| September 23, 2024 |
Resource Extraction Payment Report Exhibit 2.01 Resource Extraction Payment Report This report discloses the payments made by Albemarle Corporation to governments for the commercial development of minerals and which involve the exploration, extraction, processing and export of such minerals, or the acquisition of a license for any such activity. Unless the context otherwise indicates, the terms “Albemarle,” “we,” “us,” “our” or the |
|
| September 23, 2024 |
iso4217:USD 0000915913 alb:SalarDeAtacamaMember 2023-01-01 2023-12-31 0000915913 alb:SafiMember 2023-01-01 2023-12-31 0000915913 alb:AlbemarleCorporationMember 2023-01-01 2023-12-31 0000915913 2023-01-01 2023-12-31 0000915913 alb:CorporacionDeFomentoDeLaProduccionDeChileCorfoMember country:CL 2023-01-01 2023-12-31 0000915913 alb:TesoreriaGeneralDeLaRepublicaMember country:CL 2023-01-01 2023-12-31 |
|
| September 23, 2024 |
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT Tesoreria General de la Republica [Member] Various local Chilean municipalities/communities [Member] Income Tax Department [Member] Corporacion de Fomento de la Produccion de Chile (Corfo) [Member] Jordan Customs [Member] Social Security [Member] Albemarle Corporation [Member] Ministry of Water and Irrigation [Member] Salar de Atacama [Member] UNITED STATES Ministry of Energy [Member] Ministry of |
|
| September 10, 2024 |
ALB / Albemarle Corporation / BlackRock Inc. Passive Investment us0126531013091024.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 15) ALBEMARLE CORPORATION - (Name of Issuer) Common Stock - (Title of Class of Securities) 012653101 - (CUSIP Number) August 31, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| July 31, 2024 |
Exhibit 99.1 Contact: Meredith Bandy 1.980.999.5168 Albemarle Reports Second Quarter 2024 Results CHARLOTTE, N.C. – July 31, 2024 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2024. Second-Quarter 2024 and Recent Highlights (Unless otherwise stated |
|
| July 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| July 31, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 31, 2024 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file num |
|
| June 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-12658 A. Full title of the plan and the ad |
|
| May 10, 2024 |
’s Amended and Restated Articles of Incorporation ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF ALBEMARLE CORPORATION 1. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALBEMARLE CORPORATION (Exact name of registrant as specified in its charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 4250 Congress Street, Suite 900, Charlotte, North Carolina 28 |
|
| May 1, 2024 |
Exhibit 99.1 Contact: Meredith Bandy 1.980.999.5168 Albemarle Reports First Quarter 2024 Results CHARLOTTE, N.C. – May 1, 2024 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2024. First-Quarter 2024 and Recent Highlights (Unless otherwise stated, al |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| May 1, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 1, 2024 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| March 28, 2024 |
Financial Statements of Windfield Holdings Pty Ltd for the year ended December 31, 2023. Exhibit 99.1 WINDFIELD HOLDINGS PTY LTD ABN: 60 160 456 164 Annual Report 31 December 2023 Expressed in thousands of Australian dollars (A$000) unless otherwise stated Consolidated statement of profit or loss and other comprehensive income For the year ended 31 December 2023 2022 2021 (Unaudited) Note A$'000 A$'000 A$'000 Sales revenue 9,868,260 5,574,748 685,248 Cost of sales 4(a) (932,928) (931, |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMA |
|
| March 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy S |
|
| March 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) X Definitive Proxy |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: X Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy |
|
| March 8, 2024 |
Exhibit 4.2 7.25% SERIES A MANDATORY CONVERTIBLE PREFERRED STOCK OF ALBEMARLE CORPORATION DEPOSIT AGREEMENT among ALBEMARLE CORPORATION, EQUINITI TRUST COMPANY, LLC, as Depositary and THE HOLDERS FROM TIME TO TIME OF THE DEPOSITARY RECEIPTS DESCRIBED HEREIN Dated as of March 8, 2024 TABLE OF CONTENTS Page ARTICLE 1 DEFINED TERMS Section 1.01 . Definitions 1 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION, |
|
| March 8, 2024 |
Exhibit 1.1 ALBEMARLE CORPORATION 40,000,000 Depositary Shares Each representing a 1/20th Interest in a Share of 7.25% Series A Mandatory Convertible Preferred Stock, without par value (initial liquidation preference of $1,000 per share) Underwriting Agreement March 5, 2024 J.P. Morgan Securities LLC As Representative of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securiti |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 5, 2024 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file num |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) VIRGINIA 54-1692118 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 4250 Congress Street, Suit |
|
| March 8, 2024 |
ALBEMARLE ANNOUNCES UPSIZE AND PRICING OF PUBLIC OFFERING OF DEPOSITARY SHARES Exhibit 99.1 ALBEMARLE ANNOUNCES UPSIZE AND PRICING OF PUBLIC OFFERING OF DEPOSITARY SHARES CHARLOTTE, N.C., March 6, 2024 - Albemarle Corporation (NYSE: ALB) (“Albemarle” or the “Company”), a global leader in providing essential elements for mobility, energy, connectivity, and health, announced that it has priced its previously announced offering (the “Offering”) of 40,000,000 depositary shares ( |
|
| March 8, 2024 |
Exhibit 3.1 ARTICLES OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF ALBEMARLE CORPORATION 1. Name of Corporation. The name of the Corporation is Albemarle Corporation. 2. Text of Amendment. Article IV of the Corporation’s Amended and Restated Articles of Incorporation (the “Articles of Incorporation”) shall be amended to add Article IV.D. as set forth in Appendix A attached |
|
| March 7, 2024 |
Exhibit 107 Calculation of Filing Fee Tables 424(b)(2) (Form Type) Albemarle Corporation (Exact Name of Registrant as Specified in Its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title(1) Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Other Depositary Shares, each representing 1/20th of a share of 7. |
|
| March 7, 2024 |
Table of Contents Filed Pursuant to Rule 424(b)(2) Registration No. 333-269815 PROSPECTUS SUPPLEMENT (To Prospectus Dated March 4, 2024) 40,000,000 Depositary Shares Each Representing a 1/20th Interest in a Share of 7.25% Series A Mandatory Convertible Preferred Stock Albemarle Corporation 7.25% Series A Mandatory Convertible Preferred Stock We are offering 40,000,000 depositary shares (“Depositar |
|
| March 6, 2024 |
Pricing Term Sheet Free Writing Prospectus dated as of March 5, 2024 Filed pursuant to Rule 433 Relating to the Preliminary Prospectus Supplement dated March 4, 2024 to the Prospectus dated March 4, 2024 Registration No. |
|
| March 4, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3ASR (Form Type) Albemarle Corporation (Exact Name of Registrant as Specified in Its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Equity Common Stock, par value $0. |
|
| March 4, 2024 |
SUBJECT TO COMPLETION, DATED MARCH 4, 2024 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-269815 The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where |
|
| March 4, 2024 |
Consent of RESPEC regarding bromine reserves and resources. EX-23.8 Exhibit 23.8 March 4, 2024 CONSENT OF QUALIFIED PERSON RESPEC, in connection with Albemarle Corporation’s Post-Effective No. 1 to its Registration Statement on Form S-3ASR filed March 4, 2024 (the “Registration Statement”), consents to: • the incorporation by reference of the Technical Report Summaries prepared by RESPEC on certain bromine reserves and resources controlled by Albemarle Cor |
|
| March 4, 2024 |
As filed with the Securities and Exchange Commission on March 4, 2024 Table of Contents As filed with the Securities and Exchange Commission on March 4, 2024 Registration No. |
|
| March 4, 2024 |
Consent of RPS Energy Canada Ltd regarding bromine reserves and resources. EX-23.7 Exhibit 23.7 March 4, 2024 CONSENT OF QUALIFIED PERSON RPS Energy Canada Ltd. (“RPS”), in connection with Albemarle Corporation’s Post-Effective Amendment No. 1 to its Registration Statement on Form S-3ASR filed March 4, 2024 (the “Registration Statement”), consents to: • the incorporation by reference of the Technical Report Summaries prepared by RPS on certain bromine reserves and resour |
|
| February 15, 2024 |
Exhibit 10.52 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of February 9, 2024 (this “Amendment”), is entered into among ALBEMARLE CORPORATION, a Virginia corporation (the “Company”), ALBEMARLE EUROPE SRL, a société à responsabilité limitée organized under the laws of Belgium (“Belgian Borrower” and, together with the Company and any other Subsidiary of th |
|
| February 15, 2024 |
Exhibit 21.1 SUBSIDIARIES OF ALBEMARLE CORPORATION NAME PLACE OF FORMATION ACI Cyprus, L.L.C. Delaware Albemarle Amendments, LLC Delaware Albemarle Argentina S.R.L. Argentina Albemarle Australia Company Pty Ltd Australia Albemarle Australia Holding Company Pty Ltd Australia Albemarle Chemical Canada Ltd. Canada Albemarle Chemicals (Shanghai) Co., Ltd. China Albemarle Chemicals Ltd Cyprus Albemarle |
|
| February 15, 2024 |
Exhibit 96.1 SEC Technical Report Summary Pre-Feasibility Study Greenbushes Mine Western Australia Effective Date: June 30, 2023 Report Date: February 9, 2024 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 999 Seventeenth Street, Suite 400 Denver, CO 80202 SRK Project Number: USPR001765 SRK Con |
|
| February 15, 2024 |
Exhibit 96.2 SEC Technical Report Summary Initial Assessment Wodgina Western Australia Effective Date: December 31, 2022 Report Date: February 14, 2023 Report Prepared for Albemarle Corporation 4250 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 999 Seventeenth Street, Suite 400 Denver, CO 80202 SRK Project Number: USPR000574 SRK Consulting |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMARLE CORPORATION (Exa |
|
| February 15, 2024 |
Exhibit 97 ALBEMARLE CORPORATION INCENTIVE-BASED COMPENSATION RECOVERY POLICY Section 1. |
|
| February 15, 2024 |
JORDAN BROMINE OPERATION Technical Report Summary as of December 31, 2023 214554 Final 14 February 2024 Exhibit 96. |
|
| February 15, 2024 |
Exhibit 10.54 ALBEMARLE CORPORATION COMPENSATION RECOUPMENT AND FORFEITURE POLICY Section 1. Purpose. The purpose of this policy (this “Policy”) is to enable Albemarle Corporation (the “Corporation”) to recover erroneously awarded compensation upon Misconduct. This Policy is effective on December 1, 2023. Where the context requires, references to the Corporation include the Corporation’s subsidiar |
|
| February 15, 2024 |
Exhibit 96.6 MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2023 Magnolia, Arkansas, USA, property of Albemarle Corporation 220830 Final 14 February 2024 rpsgroup.com RESERVE EVALUATION MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2023 Magnolia, Arkansas, USA, property of Albemarle Corporation Approval for issue Michael Gallup, P. Eng. [email protected] 14 February 2024 This re |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 14, 2024 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| February 14, 2024 |
Exhibit 99.1 Contact: Meredith Bandy 1.980.999.5168 Albemarle Reports Fourth Quarter and Full Year 2023 Results Full-Year Net Sales Increase of 31%, Driven by 21% Volume Growth CHARLOTTE, N.C. – Feb. 14, 2024 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the fourth quarter and full |
|
| February 13, 2024 |
ALB / Albemarle Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0220-albemarlecorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Albemarle Corp Title of Class of Securities: Common Stock CUSIP Number: 012653101 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the r |
|
| February 9, 2024 |
ALB / Albemarle Corporation / Capital International Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Albemarle Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 012653101 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to des |
|
| February 9, 2024 |
SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Albemarle Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 012653101 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEM |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 1, 2023 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| November 1, 2023 |
Exhibit 99.1 Contact: Meredith Bandy 1.980.999.5168 Albemarle Reports Net Sales Increase of 10% for Third Quarter 2023 CHARLOTTE, N.C. – Nov. 1, 2023 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the third quarter ended September 30, 2023. Third-Quarter 2023 and Recent Highlights ( |
|
| October 26, 2023 |
ALBEMARLE ANNOUNCES NEW CHIEF FINANCIAL OFFICER EXHIBIT 99.1 Press Release ALBEMARLE ANNOUNCES NEW CHIEF FINANCIAL OFFICER CHARLOTTE, N.C., Oct. 26, 2023 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today announced that Neal Sheorey will join Albemarle as its executive vice president and chief financial officer, effective Nov. 6, 2023. Scott Tozier, Albemarl |
|
| October 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File |
|
| October 26, 2023 |
EXHIBIT 3.1 ALBEMARLE CORPORATION AMENDED AND RESTATED BYLAWS (Effective October 23, 2023) Article I Meetings of Shareholders Section 1.Places of Meetings. All meetings of the shareholders shall be held at such place, either within or without the Commonwealth of Virginia, as may, from time to time, be fixed by the Board of Directors (the “Board”). The Board may, in its sole discretion, permit shar |
|
| October 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File |
|
| August 2, 2023 |
Exhibit 99.1 Contact: Brook Wootton 1.980.299.5700 Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023 CHARLOTTE, N.C. – Aug. 2, 2023 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights (Unl |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 2, 2023 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file nu |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-12658 A. Full title of the plan and the ad |
|
| May 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 3, 2023 |
Exhibit 10.7 Albemarle Corporation 4250 Congress Street, Suite 900 Charlotte, NC 28209 March 15, 2023 J. Kent Masters, Jr. Dear Kent: The Board of Directors (the “Board”) of Albemarle Corporation (the “Corporation”) recognizes that the possibility of a Change in Control of the Corporation exists, and the uncertainty and questions which it may raise among management may result in the departure or d |
|
| May 3, 2023 |
Exhibit 10.6 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is made on March 15, 2023 by and between Albemarle Corporation, a Virginia corporation, and J. Kent Masters, Jr. (the “Executive”). References herein to the “Company” shall mean Albemarle Corporation and, where appropriate, each and any of its divisions, affil |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 3, 2023 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| May 3, 2023 |
Exhibit 99.1 Contact: Brook Wootton 1.980.299.5700 Albemarle Reports Net Sales Increase of 129% for First Quarter 2023 CHARLOTTE, N.C. – May 3, 2023 - Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2023. First-Quarter 2023 and Recent Highlights (Unles |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| May 2, 2023 |
Consent of RESPEC regarding bromine reserves and resources. Exhibit 23.7 May 2, 2023 CONSENT OF QUALIFIED PERSON RESPEC, in connection with Albemarle Corporation’s Registration Statement on Form S-8 filed May 2, 2023 (the “Registration Statement”), consents to: •the incorporation by reference of the Technical Report Summaries prepared by RESPEC on certain bromine reserves and resources controlled by Albemarle Corporation (the “Technical Report Summaries”), |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALBEMARLE CORPORATION (Exact name of registrant as specified in its charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 4250 Congress Street, Suite 900, Charlotte, North Carolina 28 |
|
| May 2, 2023 |
As filed with the Securities and Exchange Commission on May 2, 2023 As filed with the Securities and Exchange Commission on May 2, 2023 Registration No. |
|
| May 2, 2023 |
Calculation of Filing Fee Tables ……Form S-8…….. (Form Type) …………….…………… Albemarle Corporation ………………………….. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amo |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMA |
|
| April 21, 2023 |
Financial Statements of Windfield Holdings Pty Ltd for the year ended December 31, 2022. Exhibit 99.1 WINDFIELD HOLDINGS PTY LTD ABN: 60 160 456 164 Annual Report 31 December 2022 Expressed in thousands of Australian dollars (A$000) unless otherwise stated Consolidated statement of profit or loss and other comprehensive income For the year ended 31 December 2022 2021 2020 (Unaudited) (Unaudited) Note A$'000 A$'000 A$'000 Sales revenue 5,574,748 685,248 402,925 Cost of sales 4(a) (931, |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy S |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) X Definitive Proxy |
|
| March 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File N |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 24, 2023 |
EXHIBIT 10.2 [Form of Employee rTSR PSU Award with Three-Year Measurement Period] PERFORMANCE UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of [●], 20[●], Albemarle Corporation, a Virginia corporation (the “Company”), and [●] (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as |
|
| February 24, 2023 |
EXHIBIT 10.3 [Form of Employee ROIC PSU Award with Three-Year Measurement Period] PERFORMANCE UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of [●], 20[●], Albemarle Corporation, a Virginia corporation (the “Company”), and [●] (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as |
|
| February 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 24, 2023 |
EXHIBIT 10.1 [Form of Employee Stock Option Award with Three-Year Cliff Vest] STOCK OPTION AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of [●], 20[●], Albemarle Corporation, a Virginia corporation (the “Company”), and [●] (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as defined |
|
| February 24, 2023 |
EXHIBIT 10.5 [Form of Employee Special RSU Award with Three-Year Cliff Vest] RESTRICTED STOCK UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of [●], 20[●], Albemarle Corporation, a Virginia corporation (the “Company”), and [●] (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as |
|
| February 24, 2023 |
EXHIBIT 10.4 [Form of Employee RSU Award with Three-Year Cliff Vest] RESTRICTED STOCK UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of [●], 20[●], Albemarle Corporation, a Virginia corporation (the “Company”), and [●] (“Participant”) hereby agree to the terms of this Award Agreement (this “Agreement”), which reflects the terms and conditions of this Award (as defined |
|
| February 16, 2023 |
Statement of Eligibility on Form T-1 of U.S. Bank National Association, as Trustee EX-25.1 10 exhibit251forms-3asr.htm EX-25.1 Exhibit 25.1 Securities and Exchange Commission Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) ☐ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as s |
|
| February 16, 2023 |
As filed with the Securities and Exchange Commission on February 15, 2023 As filed with the Securities and Exchange Commission on February 15, 2023 Registration No. |
|
| February 16, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2023 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 16, 2023 |
Exhibit 99.1 Albemarle Corporation and Subsidiaries Consolidated Summary of Segment Results (In Thousands) (Unaudited) The Company’s chief operating decision maker uses adjusted EBITDA (as defined below) to assess the ongoing performance of the Company’s business segments and to allocate resources. We define adjusted EBITDA as earnings before interest and financing expenses, income tax expense, de |
|
| February 16, 2023 |
Consent of RESPEC regarding bromine reserves and resources. Exhibit 23.7 February 15, 2023 CONSENT OF QUALIFIED PERSON RESPEC, in connection with Albemarle Corporation’s Registration Statement on Form S-3ASR filed February 15, 2023 (the “Registration Statement”), consents to: •the incorporation by reference of the Technical Report Summaries prepared by RESPEC on certain bromine reserves and resources controlled by Albemarle Corporation (the “Technical Repo |
|
| February 16, 2023 |
Exhibit 107 Calculation of Filing Fee Tables ……Form S-3ASR…….. (Form Type) …………….…………… Albemarle Corporation ………………………….. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee |
|
| February 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 15, 2023 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| February 15, 2023 |
Exhibit 99.1 Contact: Brook Wootton 980.299.5700 Albemarle Reports Net Sales Increase ~3x for Fourth Quarter 2022; Full-Year Net Sales Over $7 Billion CHARLOTTE, NC - Feb. 15, 2023 – Albemarle Corporation (NYSE: ALB), a global leader in transforming essential resources such as lithium and bromine into critical ingredients for mobility, energy, connectivity and health, today announced its results f |
|
| February 15, 2023 |
Exhibit 96.5 MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2022 Magnolia, Arkansas, USA, property of Albemarle Corporation 214554 Final 15 February 2023 rpsgroup.com RESERVE EVALUATION MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2022 Magnolia, Arkansas, USA, property of Albemarle Corporation Approval for issue Michael Gallup, P. Eng. [email]: [email protected] 15 February 202 |
|
| February 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 15, 2023 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| February 15, 2023 |
Exhibit 96.2 SEC Technical Report Summary Pre-Feasibility Study Salar de Atacama Región II, Chile Effective Date: August 31, 2022 Report Date: February 14, 2023 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 999 Seventeenth Street, Suite 400 Denver, CO 80202 SRK Project Number: USPR000574 SRK C |
|
| February 15, 2023 |
Exhibit 96.4 JORDAN BROMINE OPERATION Technical Report Summary as of December 31, 2022 214554 Final 15 February 2023 respec.com rpsgroup.com TECHNICAL REPORT SUMMARY JORDAN BROMINE OPERATION Technical Report Summary Peer Review Michael Gallup, P. Eng. [email]: [email protected] 10 February 2023 Approval for issue Michael Gallup, P. Eng. [email]: [email protected] 10 February 20 |
|
| February 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMARLE CORPORATION (Exa |
|
| February 15, 2023 |
Exhibit 96.3 SEC Technical Report Summary Pre-Feasibility Study Silver Peak Lithium Operation Nevada, USA Effective Date: September 30, 2022 Report Date: February 14, 2023 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 999 Seventeenth Street, Suite 400 Denver, CO 80202 SRK Project Number: USPR0 |
|
| February 15, 2023 |
Exhibit 96.1 SEC Technical Report Summary Pre-Feasibility Study Greenbushes Mine Western Australia Effective Date: December 31, 2022 Report Date: February 14, 2023 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 999 Seventeenth Street, Suite 400 Denver, CO 80202 SRK Project Number: USPR000574 SR |
|
| February 15, 2023 |
Exhibit 21.1 SUBSIDIARIES OF ALBEMARLE CORPORATION NAME PLACE OF FORMATION ACI Cyprus, L.L.C. Delaware Albemarle Amendments, LLC Delaware Albemarle Argentina S.R.L. Argentina Albemarle Brazil Holdings Ltda. Brazil Albemarle Care Fund Virginia Albemarle Catalysts Company B.V. Netherlands Albemarle Chemical Canada Ltd. Canada Albemarle Chemicals (Shanghai) Co., Ltd. China Albemarle Chemicals Ltd Cyp |
|
| February 13, 2023 |
ALB / Albemarle Corporation / Capital International Investors - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Albemarle Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 012653101 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa |
|
| February 9, 2023 |
ALB / Albemarle Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0197-albemarlecorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Albemarle Corp. Title of Class of Securities: Common Stock CUSIP Number: 012653101 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the |
|
| January 26, 2023 |
Exhibit 96.5 JORDAN BROMINE OPERATION Technical Report Summary as of December 31, 2021 214554 Final 26 January 2023 respec.com rpsgroup.com TECHNICAL REPORT SUMMARY JORDAN BROMINE OPERATION Technical Report Summary Approval for issue Michael Gallup, P. Eng. [email]: [email protected] 26 January 2023 This report was prepared by RPS Energy Canada Ltd (‘RPS’) within the terms of its engagem |
|
| January 26, 2023 |
Exhibit 96.6 MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2021 Magnolia, Arkansas, USA, property of Albemarle Corporation 214554 Final 26 January 2023 rpsgroup.com RESERVE EVALUATION MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2021 Magnolia, Arkansas, USA, property of Albemarle Corporation Approval for issue Michael Gallup, P. Eng. [email]: [email protected] 26 January 2023 |
|
| January 26, 2023 |
Exhibit 96.3 SEC Technical Report Summary Pre-Feasibility Study Salar de Atacama Región II, Chile Effective Date: August 31, 2021 Report Date: January 28, 2022 Amended Date: December 16, 2022 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80202 SRK |
|
| January 26, 2023 |
CORRESP 1 filename1.htm January 26, 2023 Ken Schuler and Craig Arakawa Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Albemarle Corporation Form 10-K for Fiscal Year Ended December 31, 2021 Filed February 22, 2022 File No. 001-12658 Dear Mr. Schuler and Mr. Arakawa: We are supplementing t |
|
| January 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 2) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMA |
|
| January 26, 2023 |
Exhibit 96.2 SEC Technical Report Summary Initial Assessment Wodgina Western Australia Effective Date: September 30, 2020 Report Date: December 31, 2021 Amended Date: December 16, 2022 Report Prepared for Albemarle Corporation 4250 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80202 SRK Project |
|
| January 26, 2023 |
Exhibit 96.4 SEC Technical Report Summary Pre-Feasibility Study Silver Peak Lithium Operation Nevada, USA Effective Date: June 30, 2021 Report Date: September 30, 2021 Amended Date: December 16, 2022 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80 |
|
| January 26, 2023 |
Exhibit 96.1 SEC Technical Report Summary Pre-Feasibility Study Greenbushes Mine Western Australia Effective Date: June 30, 2021 Report Date: January 28, 2021 Amended Date: December 16, 2022 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80202 SRK P |
|
| January 24, 2023 |
Albemarle to Host 2023 Strategic Update Including New 5-Year Outlook and Preliminary 2022 Results Exhibit 99.1 Contact: Brook Wootton 980.299.5700 Albemarle to Host 2023 Strategic Update Including New 5-Year Outlook and Preliminary 2022 Results CHARLOTTE, NC - Jan. 23, 2023 – Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, will host its virtual 2023 Strategy Update tomorrow, Jan. 24, 2023, at 9:00 a.m. ET. The event is expected to conclude at approximate |
|
| January 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 23, 2023 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| January 9, 2023 |
January 9, 2023 Ken Schuler and Craig Arakawa Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F Street, N. |
|
| December 27, 2022 |
December 27, 2022 Ken Schuler, Craig Arakawa Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F Street, N. |
|
| December 1, 2022 |
CORRESP 1 filename1.htm December 1, 2022 Ken Schuler and Craig Arakawa Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Albemarle Corporation Form 10-K for Fiscal Year Ended December 31, 2021 Filed February 22, 2022 File No. 001-12658 Dear Mr. Schuler and Mr. Arakawa: We are responding to t |
|
| November 16, 2022 |
CORRESP 1 filename1.htm November 16, 2022 Ken Schuler, Craig Arakawa Division of Corporation Finance Office of Industrial Applications and Services Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Albemarle Corporation Form 10-K for Fiscal Year Ended December 31, 2021 Filed February 22, 2022 File No. 001-12658 Dear Mr. Schuler and Mr. Arakawa: In your letter dated Nov |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 2, 2022 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| November 2, 2022 |
Exhibit 10.1 Execution Version Published CUSIP: 01265LAR2 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of October 28, 2022 among ALBEMARLE CORPORATION, (the ?Company?), CERTAIN OTHER SUBSIDIARIES OF THE COMPANY, THE LENDERS PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent and Swing Line Lender, JPMORGAN CHASE BANK, N.A., as Syndication Agent GOLDMAN SACHS BANK USA, MUFG BANK, LTD., B |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEM |
|
| November 2, 2022 |
Exhibit 99.1 Contact: Brook Wootton 980.299.5700 Albemarle Reports Net Sales Increase of 152% for Third Quarter 2022 CHARLOTTE, N.C. – Nov. 2, 2022 - Albemarle Corporation (NYSE: ALB) today announced its results for the third quarter ended Sept. 30, 2022. Third-Quarter 2022 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) •Net sales of $2 |
|
| November 2, 2022 |
Exhibit 10.2 Special Retention RSU Grant with Full Vesting on Early Termination RESTRICTED STOCK UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of the day of , 20, Albemarle Corporation, a Virginia corporation (the ?Company?), and ?Name? (?Participant?), hereby agree to the terms of this ?Award Agreement? which reflects the terms and provisions of the Award (as defined |
|
| October 31, 2022 |
Albemarle Announces Retirement, Appointment of General Counsel Exhibit 99.1 /C O R R E C T I O N - Albemarle Corporation/ In the news release, Albemarle Announces Retirement, Appointment of General Counsel, issued 31-Oct-2022 by Albemarle Corporation over PR Newswire, we are advised by the company that the first paragraph, second sentence, should read "Kristin M. Coleman will join the company as executive vice president, general counsel, and corporate secreta |
|
| October 31, 2022 |
Albemarle Announces Retirement, Appointment of General Counsel Exhibit 99.1 Albemarle Announces Retirement, Appointment of General Counsel CHARLOTTE, N.C., Oct. 31, 2022 - Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that Karen G. Narwold, executive vice president, chief administrative officer, general counsel, and corporate secretary, will retire from Albemarle effective April 4, 2023. Kristin M. Col |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2022 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2022 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporati |
|
| October 12, 2022 |
October 12, 2022 Sasha Parikh, Angela Connell Ken Schuler, Craig Arakawa Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, N. |
|
| September 22, 2022 |
CORRESP 1 filename1.htm September 22, 2022 Sasha Parikh, Angela Connell Ken Schuler, Craig Arakawa Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Albemarle Corporation Form 10-K for Fiscal Year Ended December 31, 2021 Filed February 22, 2022 File No. 001-12658 Dear Ms. Parikh, Ms. Connell, Mr. Schuler and Mr. A |
|
| August 3, 2022 |
Exhibit 99.1 Contact: Brook Wootton 980.299.5700 Albemarle Reports Strong Second-Quarter Sales Growth, Raising Guidance CHARLOTTE, N.C. ? Aug 3, 2022 - Albemarle Corporation (NYSE: ALB) today announced its results for the second quarter ended June 30, 2022. Second Quarter 2022 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) ?Net sales of |
|
| August 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| August 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 3, 2022 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file nu |
|
| June 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-12658 A. Full title of the plan and the ad |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALBEMARLE CORPORATION (Exact name of registrant as specified in its charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 4250 Congress Street, Suite 900, Charlotte, North Carolina 28 |
|
| May 13, 2022 |
Exhibit 4.3 (Face of Note) ALBEMARLE CORPORATION 5.050% Senior Notes Due 2032 CUSIP: 012653 AE1 ISIN: US012653AE17 No. [?] $[?] ALBEMARLE CORPORATION ALBEMARLE CORPORATION, a Virginia corporation (the ?Company?, which term includes any successor under the Indenture hereinafter referred to), for value received, promises to pay to CEDE & CO., or registered assigns, the principal sum of [?] ($[?]) on |
|
| May 13, 2022 |
Exhibit 4.4 (Face of Note) ALBEMARLE CORPORATION 5.650% Senior Notes Due 2052 CUSIP: 012653 AF8 ISIN: US012653AF81 No. [?] $[?] ALBEMARLE CORPORATION ALBEMARLE CORPORATION, a Virginia corporation (the ?Company?, which term includes any successor under the Indenture hereinafter referred to), for value received, promises to pay to CEDE & CO., or registered assigns, the principal sum of [?] DOLLARS ( |
|
| May 13, 2022 |
Albemarle Corporation Announces Redemption of All Outstanding 4.150% Senior Notes Due 2024 Exhibit 99.2 Albemarle Corporation Announces Redemption of All Outstanding 4.150% Senior Notes Due 2024 CHARLOTTE, N.C., May 13, 2022 - Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced that it intends to redeem all its outstanding 4.150% Senior Notes due 2024 (CUSIP No. 012725 AC1, ISIN No. US012725AC13) (the "Notes") on June 12, 2022 (the "Re |
|
| May 13, 2022 |
Exhibit 4.2 (Face of Note) ALBEMARLE CORPORATION 4.650% Senior Notes Due 2027 CUSIP: 012653 AD3 ISIN: US012653AD34 No. [?] $[?] ALBEMARLE CORPORATION ALBEMARLE CORPORATION, a Virginia corporation (the ?Company?, which term includes any successor under the Indenture hereinafter referred to), for value received, promises to pay to CEDE & CO., or registered assigns, the principal sum of [?] DOLLARS ( |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 13, 2022 |
BofA Securities, Inc., J.P. Morgan Securities, LLC, and Mizuho Securities USA LLC Exhibit 1.1 $1,700,000,000 ALBEMARLE CORPORATION $650,000,000 4.650% Senior Notes due 2027 $600,000,000 5.050% Senior Notes due 2032 $450,000,000 5.650% Senior Notes due 2052 Underwriting Agreement May 10, 2022 BofA Securities, Inc. J.P. Morgan Securities LLC Mizuho Securities USA LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o BofA Securities, Inc. One Bryant Pa |
|
| May 13, 2022 |
Albemarle Announces Pricing of Public Offering of Senior Notes Exhibit 99.1 Albemarle Announces Pricing of Public Offering of Senior Notes CHARLOTTE, N.C., May 11, 2022 - Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced the pricing of an underwritten public offering of senior notes consisting of: ?$650,000,000 of 4.650% senior notes due 2027, ?$600,000,000 of 5.050% senior notes due 2032, and ?$450,000,00 |
|
| May 12, 2022 |
Calculation of Filing Fee Tables 424(b)(5) (Form Type) Albemarle Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee (1) Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Debt 4. |
|
| May 12, 2022 |
Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-234547 PROSPECTUS SUPPLEMENT (to Prospectus dated November 6, 2019) $1,700,000,000 $650,000,000 of 4.650% Senior Notes due 2027 $600,000,000 of 5.050% Senior Notes due 2032 $450,000,000 of 5.650% Senior Notes due 2052 Albemarle Corporation (?Albemarle?) is offering $650,000,000 aggregate principal amount of its 4.650% Senior N |
|
| May 11, 2022 |
Filed Pursuant to Rule 433 under the Securities Act of 1933, as amended Registration Statement No. |
|
| May 10, 2022 |
SUBJECT TO COMPLETION, DATED MAY 10, 2022 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-234547 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to the securities has become effective under the Securities Act of 1933. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and we |
|
| May 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARL |
|
| May 4, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 4, 2022 |
Exhibit 99.1 Contact: Meredith Bandy 980.999.5168 Albemarle Reports First Quarter Sales Growth of 36%, Raising Guidance CHARLOTTE, N.C. ? May 4, 2022 - Albemarle Corporation (NYSE: ALB) today announced its results for the first quarter ended March 31, 2022. First Quarter 2022 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) ?Net sales of |
|
| May 4, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 4, 2022 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| March 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) X Definitive Proxy |
|
| March 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy S |
|
| March 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 09, 2022 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 9, 2022 |
Exhibit 10.1 EMPLOYEE NON-SOLICITATION, NON-COMPETE AND CONFIDENTIALITY AGREEMENT This NON-SOLICITATION, NON-COMPETE AND CONFIDENTIALITY AGREEMENT is made and entered into this day of [MONTH, YEAR] (this ?Agreement?) by and between Albemarle Corporation and its parents, affiliates, subsidiaries, successors, assigns and any other entities under their control (the ?Company?) and [EMPLOYEE NAME] (the |
|
| March 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMA |
|
| February 28, 2022 |
Exhibit 10.1 RESTRICTED STOCK UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of the day of , 20, Albemarle Corporation, a Virginia corporation (the ?Company?), and ?Name? (?Participant?), hereby agree to the terms of this ?Award Agreement? which reflects the terms and provisions of the Award (as defined below) made pursuant to and subject to the provisions of the Compa |
|
| February 28, 2022 |
Exhibit 10.2 ADJUSTED ROIC PERFORMANCE UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of the day of , 20, Albemarle Corporation, a Virginia corporation (the ?Company?), and ?Name? (?Participant?), hereby agree to the terms of this ?Award Agreement? which reflects the terms and provisions of the Award (as defined below) made pursuant to and subject to the provisions of |
|
| February 28, 2022 |
Exhibit 10.3 TSR PERFORMANCE UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of the day of , 20, Albemarle Corporation, a Virginia corporation (the ?Company?), and ?Name? (?Participant?), hereby agree to the terms of this ?Award Agreement? which reflects the terms and provisions of the Award (as defined below) made pursuant to and subject to the provisions of the Compan |
|
| February 28, 2022 |
Exhibit 10.4 STOCK OPTION GRANT AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN No. of shares subject to option: ?StockOptions? As of the day of , 20, Albemarle Corporation, a Virginia corporation (the ?Company?), and ?Name? (?Participant?), hereby agree to the terms of this ?Award Agreement? which reflects the terms and provisions of the Option (as defined below) made pursuant to an |
|
| February 28, 2022 |
Exhibit 10.5 Special Retention RSU Grant RESTRICTED STOCK UNIT AWARD AGREEMENT under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN As of the day of , 20, Albemarle Corporation, a Virginia corporation (the ?Company?), and ?Name? (?Participant?), hereby agree to the terms of this ?Award Agreement? which reflects the terms and provisions of the Award (as defined below) made pursuant to and subject to |
|
| February 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2022 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 24, 2022 |
Albemarle Corporation Appoints Ralf Cramer to Board of Directors Exhibit 99.1 Albemarle Corporation Appoints Ralf Cramer to Board of Directors CHARLOTTE, N.C., Feb. 24, 2022 - Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that its Board of Directors (the ?Board?) has appointed Ralf H. Cramer to the Board, effective February 21, 2022. Cramer will serve as a member of the Board?s Audit & Finance Committee |
|
| February 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2022 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission Fil |
|
| February 22, 2022 |
Exhibit 21.1 SUBSIDIARIES OF ALBEMARLE CORPORATION NAME PLACE OF FORMATION ACI Cyprus, L.L.C. Delaware Albemarle Argentina S.R.L. Argentina Albemarle Brazil Holdings Ltda. Brazil Albemarle Care Fund Virginia Albemarle Catalysts Company B.V. Netherlands Albemarle Chemical Canada Ltd. Canada Albemarle Chemicals (Shanghai) Co., Ltd. China Albemarle Chemicals Ltd Cyprus Albemarle Chemicals Private Lim |
|
| February 22, 2022 |
Exhibit 10.61 THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT, dated as of December 10, 2021 (this ?Amendment?), is entered into among ALBEMARLE CORPORATION, a Virginia corporation (the ?Company?), ALBEMARLE EUROPE SRL, a limited liability company organized under the laws of Belgium (?soci?t? ? responsabilit? limit?e?) (?Albemarle Europe?, and together with the Company |
|
| February 22, 2022 |
Exhibit 10.62 EXECUTION VERSION SECOND AMENDMENT AND RESTATEMENT AGREEMENT, dated as of December 10, 2021 (this ?Agreement?), among ALBEMARLE CORPORATION, a Virginia corporation (the ?Borrower?), ALBEMARLE NEW HOLDING GMBH, a Gesellschaft mit beschr?nkter Haftung incorporated under the laws of the Federal Republic of Germany (?Albemarle Germany?), the LENDERS party hereto and JPMORGAN CHASE BANK, |
|
| February 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number 001-12658 ALBEMARLE CORPORATION (Exa |
|
| February 18, 2022 |
EX-96.5 12 exhibit9651231202110-k.htm EX-96.5 Exhibit 96.5 JORDAN BROMINE OPERATION Technical Report Summary as of December 31, 2021 214554 Final 07 February 2022 respec.com rpsgroup.com TECHNICAL REPORT SUMMARY JORDAN BROMINE OPERATION Technical Report Summary Peer Review Doug Ashton, P. Eng. [email]: [email protected] 7 February 2022 Approval for issue Doug Ashton, P. Eng. [email]: doug.a |
|
| February 18, 2022 |
Exhibit 96.1 SEC Technical Report Summary Pre-Feasibility Study Greenbushes Mine Western Australia Effective Date: June 30, 2021 Report Date: January 28, 2021 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80202 SRK Project Number: 515800.040 SRK Co |
|
| February 18, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 18, 2022 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| February 18, 2022 |
Exhibit 96.3 SEC Technical Report Summary Pre-Feasibility Study Salar de Atacama Regi?n II, Chile Effective Date: August 31, 2021 Report Date: January 28, 2022 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80202 SRK Project Number: 515800.040 SRK C |
|
| February 18, 2022 |
Exhibit 96.4 SEC Technical Report Summary Pre-Feasibility Study Silver Peak Lithium Operation Nevada, USA Effective Date: June 30, 2021 Report Date: September 30, 2021 Report Prepared for Albemarle Corporation 4350 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80202 SRK Project Number: 515800.0 |
|
| February 18, 2022 |
Exhibit 96.2 SEC Technical Report Summary Initial Assessment Wodgina Western Australia Effective Date: September 30, 2020 Report Date: December 31, 2021 Report Prepared for Albemarle Corporation 4250 Congress Street Suite 700 Charlotte, North Carolina 28209 Report Prepared by SRK Consulting (U.S.), Inc. 1125 Seventeenth Street, Suite 600 Denver, CO 80202 SRK Project Number: 515800.040 SRK Consulti |
|
| February 18, 2022 |
Exhibit 96.6 MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2021 Magnolia, Arkansas, USA, property of Albemarle Corporation 214554 Final 07 February 2022 rpsgroup.com RESERVE EVALUATION MAGNOLIA FIELD BROMINE RESERVES AS OF DECEMBER 31, 2021 Magnolia, Arkansas, USA, property of Albemarle Corporation Approval for issue Doug Ashton [email protected] 7 February 2022 This report was prepare |
|
| February 16, 2022 |
Exhibit 99.1 Contact: David Burke 980.299.5533 Albemarle Corporation Finishes 2021 Strong; Raises 2022 Outlook CHARLOTTE, NC - Feb. 16, 2022 ? Albemarle Corporation (NYSE: ALB) today announced its results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 and Recent Highlights (Unless otherwise stated, all percent changes represent year-over-year comparisons) ?Net sa |
|
| February 16, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 16, 2022 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| February 9, 2022 |
ALB / Albemarle Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Albemarle Corp. Title of Class of Securities: Common Stock CUSIP Number: 012653101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Ru |
|
| February 3, 2022 |
ALB / Albemarle Corporation / FRANKLIN RESOURCES INC Passive Investment CUSIP NO. 012653101 13G Page 1 of 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* ALBEMARLE CORPORATION (Name of Issuer) COMMON STOCK, $.01 Par Value (Title of Class of Securities) 012653101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropri |
|
| December 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 4, 2021 |
EX-10.1 2 exhibit1010930202110q.htm EX-10.1 Exhibit 10.1 Albemarle Corporation 4250 Congress Street, Suite 900 Telephone: 980-299-5700 Charlotte, NC 28209 www.albemarle.com November 3, 2021 Raphael Crawford 2334 Central Park Circle Houston, TX 77059 Dear Raphael: On behalf of Albemarle Corporation (together with its affiliates, “Albemarle” or the “Company”), I am pleased to offer you the enhanced |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBE |
|
| November 3, 2021 |
EX-99.1 2 a3q21earningsreleaseex991.htm EX-99.1 Exhibit 99.1 Contact: David Burke 980.299.5533 Albemarle Reports Third Quarter Sales Growth of 11% and Increases Guidance CHARLOTTE, N.C. – Nov. 3, 2021 - Albemarle Corporation (NYSE: ALB) today announced its results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights (Unless otherwise stated, all percent changes are based o |
|
| November 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 3, 2021 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file |
|
| September 30, 2021 |
Exhibit 99.1 Albemarle to Expand Lithium Production Capabilities with Acquisition of Guangxi Tianyuan New Energy Materials Co., Ltd. Acquisition will add conversion capacity in China near the Port of Qinzhou CHARLOTTE, N.C., Sept. 30, 2021 - Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, announced today that its subsidiary, Albemarle Lithium UK Limited, has |
|
| September 30, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2021 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 4, 2021 |
EX-99.1 2 a2q21earningsreleaseex991.htm EX-99.1 Exhibit 99.1 Contact: David Burke 980.299.5533 Albemarle Reports Second-Quarter Results CHARLOTTE, N.C. – Aug. 4, 2021 - Albemarle Corporation (NYSE: ALB) today announced its results for the second quarter ended June 30, 2021. Second Quarter 2021 Highlights (Unless otherwise stated, all percent changes are based on year-over-year comparisons) •Net in |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARLE |
|
| August 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 4, 2021 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file nu |
|
| August 4, 2021 |
Exhibit 10.1 FOURTH AMENDMENT TO THE ALBEMARLE CORPORATION 2013 STOCK COMPENSATION AND DEFERRAL ELECTION PLAN FOR NON-EMPLOYEE DIRECTORS In accordance with Article 12 of the Albemarle Corporation 2013 Stock Compensation and Deferral Election Plan for Non-Employee Directors, as amended July 11, 2016 (the ?Plan?), the Plan is hereby amended as follows: 1. Effective January 1, 2021, Section 6.6(b) is |
|
| June 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number 001-12658 A. Full title of the plan and the ad |
|
| June 1, 2021 |
Albemarle Completes Sale of Fine Chemistry Services Business to W. R. Grace & Co. Exhibit 99.1 Albemarle Completes Sale of Fine Chemistry Services Business to W. R. Grace & Co. CHARLOTTE, N.C., June 1, 2021 - Albemarle Corporation (NYSE: ALB), a leader in the global specialty chemicals industry, today announced that it has completed the sale of its Fine Chemistry Services business to W. R. Grace & Co. for approximately $570 million, consisting of $300 million in cash, and the i |
|
| June 1, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2021 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ALBEMARLE CORPORATION (Exact name of registrant as specified in its charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 4250 Congress Street, Suite 900, Charlotte, North Carolina 28 |
|
| May 6, 2021 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2021 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 5, 2021 |
EX-99.1 2 a1q21earningsreleaseex991.htm EX-99.1 Exhibit 99.1 Contact: Meredith Bandy 980.999.5168 Albemarle Reports First Quarter Sales Growth of 12% CHARLOTTE, N.C. - May 5, 2021 - Albemarle Corporation (NYSE: ALB) today announced its results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights (Unless otherwise stated, all percent changes are based on year-over-year comparis |
|
| May 5, 2021 |
EX-10.1 2 exhibit1010331202110q.htm EX-10.1 Exhibit 10.1 SALE, PURCHASE AND CONTRIBUTION AGREEMENT BY AND AMONG ALBEMARLE CORPORATION, W. R. GRACE & CO.-CONN. And FINE CHEMICAL MANUFACTURING SERVICES LLC Dated as of February 25, 2021 TABLE OF CONTENTS Page Article I DEFINITIONS 2 Section 1.1 2021 Bonus Stub Period. 2 Section 1.2 2021 Bonus Stub Period Performance Bonuses. 2 Section 1.3 Accrued 202 |
|
| May 5, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 5, 2021 ALBEMARLE CORPORATION (Exact name of Registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission file numbe |
|
| May 5, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For Quarterly Period Ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-12658 ALBEMARL |
|
| March 31, 2021 |
Exhibit 4.1 SIXTH SUPPLEMENTAL INDENTURE SIXTH SUPPLEMENTAL INDENTURE, dated as of March 30, 2021 (this ?Sixth Supplemental Indenture?), among Albemarle Corporation, a Virginia corporation (the ?Company?), whose principal office is located at 4250 Congress Street, Suite 900, Charlotte, North Carolina 28209, Albemarle New Holding GmbH (?New Holding?), Gesellschaft mit beschr?nkter Haftung incorpora |
|
| March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2021 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) X |
|
| March 23, 2021 |
DEFA14A 1 a2021defa14a-noticeaccess.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant X Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Comm |
|
| March 15, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2021 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 15, 2021 |
Albemarle Announces Upsize and Early Results of Cash Tender Offers EX-99.2 3 a03-15x20218xkex992tendere.htm EX-99.2 Exhibit 99.2 Albemarle Announces Upsize and Early Results of Cash Tender Offers CHARLOTTE, N.C. – March 15, 2021 - Albemarle Corporation (the “Company”) (NYSE: ALB) today announced the upsize and early results of the previously announced cash tender offers by the Company and two of its wholly-owned subsidiaries, Albemarle Wodgina Pty Ltd (ACN 630 50 |
|
| March 15, 2021 |
Albemarle Announces Pricing of Cash Tender Offers EX-99.1 2 a03-15x20218xkex991tenderp.htm EX-99.1 Exhibit 99.1 Albemarle Announces Pricing of Cash Tender Offers CHARLOTTE, N.C. – March 12, 2021 - Albemarle Corporation (the “Company”) (NYSE: ALB) today announced the pricing of the previously announced cash tender offers by the Company and two of its wholly-owned subsidiaries, Albemarle Wodgina Pty Ltd (“Wodgina”) and Albemarle New Holding GmbH (“ |
|
| March 1, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2021 ALBEMARLE CORPORATION (Exact name of registrant as specified in charter) Virginia 001-12658 54-1692118 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 1, 2021 |
Form of Notice of Restricted Stock Unit Award Exhibit 10.1 NOTICE OF RESTRICTED STOCK UNIT AWARD under the ALBEMARLE CORPORATION 2017 INCENTIVE PLAN This AWARD, made as of the day of , 20, by Albemarle Corporation, a Virginia corporation (the ?Company?), to ?Name? (?Participant?), is made pursuant to and subject to the provisions of the Company?s 2017 Incentive Plan (the ?Plan?). All terms that are used herein that are defined in the Plan sha |
